Compare
QT Imaging Holdings, Inc. vs Hyperfine, Inc. vs Escalon Medical Corp vs Precision Optics Corporation, Inc.
| Latest fiscal year | QT Imaging Holdings, Inc. QTI | Hyperfine, Inc. HYPR | Escalon Medical Corp ESMC | Precision Optics Corporation, Inc. POCI |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-06-30 | 2026-06-30 |
| Revenue | $18.93M | $13.56M | $12.74M | $31.53M |
| Revenue growth (YoY) | +287.9% | +5.2% | +5.7% | +65.2% |
| Gross margin | 45.4% | 49.8% | 43.7% (computed) | 17.2% |
| Operating margin | -23.4% | -273.4% | 0.4% | -11.1% |
| Net margin | -111.4% | -262.3% | 31.5% | -11.5% |
| Net income | -$21.08M | -$35.57M | $4.01M | -$3.63M |
| EPS (Diluted) | -$2.01 | -$0.43 | $0.27 | -$0.43 |
| Operating cash flow | -$8.96M | -$27.95M | -$402.6K | -$1.55M |
| Free cash flow | -$9.08M | -$29.13M | -$407.0K | -$1.98M |
| Cash & equivalents | $10.41M | $35.09M | $3.07M | $9.84M |
| Total assets | $23.02M | $55.26M | $9.13M | $32.34M |
| Total liabilities | $16.58M | $14.26M | $3.20M | $11.99M |
| Shareholders' equity | $6.45M | $41.01M | $5.93M | $20.35M |
| Return on year-end equity | -327.1% | -86.8% | 67.7% | -17.8% |
| Shares outstanding | 11.90M | n/a | 7.42M | 10.97M |
Revenue, most recent five fiscal years
| Fiscal year | QT Imaging Holdings, Inc. | Hyperfine, Inc. | Escalon Medical Corp | Precision Optics Corporation, Inc. |
|---|---|---|---|---|
| Latest | $18.93M Ended 2025-12-31 | $13.56M Ended 2025-12-31 | $12.74M Ended 2026-06-30 | $31.53M Ended 2026-06-30 |
| 1 year earlier | $4.88M Ended 2024-12-31 | $12.89M Ended 2024-12-31 | $12.05M Ended 2025-06-30 | $19.09M Ended 2025-06-30 |
| 2 years earlier | $40.4K Ended 2023-12-31 | $11.03M Ended 2023-12-31 | $11.98M Ended 2024-06-30 | $19.10M Ended 2024-06-30 |
| 3 years earlier | n/a | $6.81M Ended 2022-12-31 | $12.18M Ended 2023-06-30 | $21.04M Ended 2023-06-30 |
| 4 years earlier | n/a | $1.50M Ended 2021-12-31 | $10.70M Ended 2022-06-30 | $15.68M Ended 2022-06-30 |